Concepedia

Ted Okerson

TO

Statistics

Publications

10

Citations

1.1K

H-Index

10

Active since

2008

Affiliations

Eli Lilly (United States)(Current)

Amgen (United States)

Allergan (United States)

University of California, Irvine

Ted Okerson is an author at Eli Lilly (United States) specializing in medicine, diabetes mellitus, and endocrinology.

Publications per year

2008–2020

10

Publications

10

Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study

Ralph A. DeFronzo, Ted Okerson, Prabhakar Viswanathan et al. · Current Medical Research and Opinion · 2008 · 374 citations

, , +17

Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug—naive patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, parallel-group study

T. Moretto, Terry Ridge, Leigh MacConell et al. · Clinical Therapeutics · 2008 · 351 citations

, , +17

Effects of Exenatide on Systolic Blood Pressure in Subjects With Type 2 Diabetes

Ted Okerson, Peijing Yan, Anthony H. Stonehouse et al. · American Journal of Hypertension · 2009 · 187 citations · Full text

, , +17

Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low‐Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients

Ted Okerson, Jeetvan Patel, Stefan DiMario et al. · Journal of the American Heart Association · 2017 · 55 citations · Full text

, , +17

Risk of lymphoma in women with breast implants

Joan Largent, Michael G. Oefelein, Hilton M. Kaplan et al. · European Journal of Cancer Prevention · 2012 · 34 citations

, , +13

1–5 of 10